People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oligomerix, Inc. | — | Pharmaceuticals | Seed | $8.3M | $37.8M | 2012 |
| NovaRay Medical, Inc. | — | Other Health Care | Series A | $7.2M | $26.2M | 2009 |
David Dantzker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Dantzker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Foster | 1 | 3 |
| William Frederick | 1 | 3 |
| Jeffrey Bluestein | 1 | 2 |
| Victor Micati | 1 | 1 |
| Robert Forester | 1 | 1 |
| William Erhardt | 1 | 1 |
| Eliot Davidowitz | 1 | 1 |
| Jun Shik Yu | 1 | 1 |
| Carl Kleidman | 1 | 1 |
| Lynda Wijcik | 1 | 1 |
| Marc Whyte | 1 | 1 |
| George Hersbach | 1 | 1 |
| Douglas Durand | 1 | 1 |
| Jack Price | 1 | 1 |
| James Moe | 1 | 1 |
| Jack Pasini | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.